Deal Snapshot
Aurora Cannabis Closes Acquisition of US-based Hemp-Derived CBD Products Firm Reliva
Friday 29 May 2020

Canada-based cannabinoids company Aurora Cannabis Inc (NYSE: ACB) (TSX: ACB) has completed the previously announced acquisition of US-based hemp-derived CBD products producer Reliva, LLC for approximately USD 40m of Aurora common shares, the company said.

The transaction also includes a potential earn-out of up to a maximum of USD 45m payable at Aurora's option in shares or cash contingent upon Reliva achieving certain financial targets over the next two years.

Date Published: 29/05/2020